These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Reuning U; Magdolen V; Hapke S; Schmitt M Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381 [TBL] [Abstract][Full Text] [Related]
4. Role of integrins in invasion of endometrial cancer cell lines. Prifti S; Zourab Y; Koumouridis A; Bohlmann M; Strowitzki T; Rabe T Gynecol Oncol; 2002 Jan; 84(1):12-20. PubMed ID: 11748970 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor type-1: its structure, biological activity and role in tumorigenesis (Review). Chorostowska-Wynimko J; Skrzypczak-Jankun E; Jankun J Int J Mol Med; 2004 Jun; 13(6):759-66. PubMed ID: 15138609 [TBL] [Abstract][Full Text] [Related]
6. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma. Wang J; Guo F; Wei H; Dong J; Wu J Br J Oral Maxillofac Surg; 2006 Dec; 44(6):515-9. PubMed ID: 16356605 [TBL] [Abstract][Full Text] [Related]
7. The role of the plasminogen activation system in angiogenesis and metastasis. Rabbani SA; Mazar AP Surg Oncol Clin N Am; 2001 Apr; 10(2):393-415, x. PubMed ID: 11382594 [TBL] [Abstract][Full Text] [Related]
8. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin. Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693 [TBL] [Abstract][Full Text] [Related]
9. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling. Madsen CD; Sidenius N Eur J Cell Biol; 2008 Sep; 87(8-9):617-29. PubMed ID: 18353489 [TBL] [Abstract][Full Text] [Related]
13. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1. Whitley BR; Church FC Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925 [TBL] [Abstract][Full Text] [Related]
14. Novel effector function for an old receptor. Klein R Nat Cell Biol; 2002 Jan; 4(1):E11-2. PubMed ID: 11780135 [No Abstract] [Full Text] [Related]
15. Membrane-type 1 matrix metalloproteinase modulates focal adhesion stability and cell migration. Takino T; Watanabe Y; Matsui M; Miyamori H; Kudo T; Seiki M; Sato H Exp Cell Res; 2006 May; 312(8):1381-9. PubMed ID: 16473349 [TBL] [Abstract][Full Text] [Related]
16. Cell motility. Making connections count. Lauffenburger DA Nature; 1996 Oct; 383(6599):390-1. PubMed ID: 8837766 [No Abstract] [Full Text] [Related]
17. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
18. Endothelial cell adhesion and migration. Reinhart-King CA Methods Enzymol; 2008; 443():45-64. PubMed ID: 18772010 [TBL] [Abstract][Full Text] [Related]
19. Integrins and angiogenesis. Stupack DG; Cheresh DA Curr Top Dev Biol; 2004; 64():207-38. PubMed ID: 15563949 [TBL] [Abstract][Full Text] [Related]